Lifestyle modifications: A key to manage diabetes
DOI:
https://doi.org/10.30574/gscbps.2020.13.3.0405Keywords:
Diabetes, Lifestyle modifications, Blood sugar level, ExerciseAbstract
Diabetes is one of the leading challenges to the health care or`ganization across world. Worldwide, 422 million peoples suffering from diabetes 1. Diabetes mellitus is a metabolic disorder which is characterized by abnormal metabolism of carbohydrates, fats, protein. The main etiological factors contributes in the development of diabetes are sedentary lifestyle, obesity, intake of junk foods. It is mandatory to manage increased blood sugar level (BSL) to prevent microvascular as well as macrovascular complications.
To manage diabetes, metformin and insulin play a key role hence these two medications added in the diabetes pharmacotherapy. Diabetes is not a treatable disease hence we have to maintain weight by doing regular exercise and implementation of dietary modifications.
It is important to maintain the balance of daily calories intake and their utilization by practicing physical activity remain the primary and most effective prevention strategy for diabetes management. A management strategy basically involves promotion of effective weight loss and physical exercise, but it is compulsory to do exercise and follow dietary modifications regularly.
This is a comprehensive review which focuses on lifestyle modifications in diabetes. How lifestyle modification play a key role in the management of both type of diabetes along with pharmacotherapy.
Metrics
References
International Diabetes Federation. 2019.
Joseph T. Dipiro RLTGCYGRMBGWLMP. Pharmacotherapy: A pathophysiologic approach. 7th ed. New Delhi: McGraw Hill Medical Publication.
Magkos F YMCJMC. Management of the metabolic syndrome and type 2 diabetes through lifestyle modification. National Library of Medicine. 2009; 223–256.
Jakicic JM OA. Physical activity considerations for the treatment and prevention of obesity. Am J Clin Nutr. 2005; 82(Supplement 1): 226S–229S.
Anderson BJ MA. Psychological issues in the treatment of diabetes. In: RS IB, ed. Joslin’s Diabetes Deskbook. 2nd ed. Boston. 2007.
US Department of Health and Human Services US. Dietary guidelines for Americans. 6th ed. Washington DC: US Government Printing Office. 2005.
Powers MA, BJCMea. Diabetes Self-management Education and support in Type 2 Diabetes. In American Association of Diabetes Educators AoNaD, ed
Linda Haas dMM. National Standards for Diabetes self-management education and support. Diabetes Care. January 2014; Supplement 1: 44-53.
Aslak Steinsbekk 1, *, LRMLMBRaAF. Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. BMC Health Services Research. 2012; 12: 1-19.
Deakin T MCCJWR. Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. April 2005.
Carroll S DM. What is the relationship between exercise and metabolic abnormalities? Review of the metabolic syndrome. Sports Med. review of the metabolic syndrome. Sports Med.; 34(6): 371–418.
Katzmarzyk PT HK. The role of physical activity and fitness in the prevention and treatment of metabolic syndrome. Curr Cardiovasc Risk Rep. 2007; 1(3): 228–236.
Sisson SB CSCTTLCJWKP. Accelerometer-determined steps/day and metabolic syndrome. Am J Prev Med. 2010; 38(6): 575-582.
Bandura A. Social foundations of thought and action: A social cognitive theory. APA PsycInfo. 1986.
Wilson GT ST. The transtheoretical model and motivational interviewing in the treatment of eating and weight disorders. Clinical Psychology Review. 2004; 24(3): 361-378.
Foster GD WHHJea. A randomized trial of a low-carbohydrate diet for obesity. The New England Journal of Medicine. May 2003; 348(21): 2082-2090.
Samaha FF INSPea. A low-carbohydrate as compared with a low-fat diet in severe obesity. The new England Journal of Medicine. 2003; 348(21): 2074-2081.
Wing RR, VEJJPBLW. Lifestyle intervention in overweight individuals with a family history of diabetes. American Diabetes Association, Diabetic Care. 1998; 21(3): 350-359.
Park S PHTFea. Year-long physical activity and metabolic syndrome in older Japanese adults: cross-sectional data. J Gerontol A Biol Sci Med. 2008; 63(10): 1119-1123.
Greenway FL FKPRea. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicenter, randomized, double-blind, placebo-controlled, phase 3 trial. Lancet. 2010; 376(9741): 595-605.
Perry MG SSJCJ. Strategies for improving maintenance of weight loss. Toward a continuous care model of obesity management. ADA, Diabetes Care. 1993; 16(1): 200-209.
Nene EA JTUGKA. Management of type 2 diabetes: evolving strategies for the treatment of patients with type 2 diabetes. Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, The University of Tennessee Health Science Center, Memphis, TN 38163, USA. 2011; 60: 1-23.
Association AD.When You're Sick." Diabetes Spectrum/Patient Information: "Be Prepared: Sick Day Management. 2002.
Egede LE ZDSK. Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. 2002; 3: 464-470.
Katon W FCC. Treatment of depression in patients with diabetes: efficacy, effectiveness and maintenance trials and new service models. In: Katon W MMS, ed. Depression and Diabetes: John Wiley & Sons. 2010.
Torgerson JS HJBMSL. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. American Diabetes Association: Diabetes Care. 2004; 27(1): 155-161.
U.S. Food and Drug Administration. Early Communication About an Ongoing Safety Review Orlistat (Marketed as Alli and Xenical). 2009.
Miller WR RS. Motivational Interviewing. 2002.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
